196597-16-7 Usage
Description
N-(2-(2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethyl)propionamide is a complex organic chemical compound characterized by its molecular formula C18H23NO2. It is a propionamide derivative that features a tetrahydro-1H-indeno[5,4-b]furan-8-yl group, which may contribute to its potential pharmacological properties. N-(2-(2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethyl)propionamide is of interest in medicinal chemistry due to the known effects of propionamide derivatives, such as anti-inflammatory and analgesic activities.
Uses
Used in Pharmaceutical Industry:
N-(2-(2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethyl)propionamide is used as a potential active pharmaceutical ingredient for its possible anti-inflammatory and analgesic effects. N-(2-(2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethyl)propionamide's unique structure, including the tetrahydro-1H-indeno[5,4-b]furan-8-yl group, suggests it may offer novel therapeutic benefits, which are currently under investigation.
Further research is essential to explore the full chemical and biological profile of N-(2-(2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethyl)propionamide, as well as to determine its safety, efficacy, and ideal applications in medicine. As with any new chemical entity, rigorous testing and clinical trials are required to validate its use in treating specific conditions or diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 196597-16-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,6,5,9 and 7 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 196597-16:
(8*1)+(7*9)+(6*6)+(5*5)+(4*9)+(3*7)+(2*1)+(1*6)=197
197 % 10 = 7
So 196597-16-7 is a valid CAS Registry Number.
196597-16-7Relevant articles and documents
Efficient synthesis of [11C]ramelteon as a positron emission tomography probe for imaging melatonin receptors involved in circadian rhythms
Takashima-Hirano, Misato,Tazawa, Syusaku,Takahashi, Kazuhiro,Doi, Hisashi,Suzuki, Masaaki
, p. 1062 - 1064 (2011)
Ramelteon (TAK-375) is a novel melatonin receptor agonist that is used for clinical treatment of insomnia. The present report describes radiolabeling of ramelteon with the short-lived positron-emitter 11C (T 1/2=20.4 min) by 2 method
Pharmaceutical preparation containing copolyvidone
-
, (2008/06/13)
A stabilized preparation which comprises: a unstable drug in a polyethylene glycol-containing preparation; and a coating agent comprising a copolyvidone instead of polyethylene glycol with which the drug is coated.
Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders
-
Example 1, (2010/11/29)
A compound having the following general fomula: wherein R1 is an optionally substituted hydrocarbon, amino or heterocyclic group; R2 is H or an optionally substituted hydrocarbon group; R3 is H or an optionally substituted hydrocarbon or heterocyclic group; X is CHR4, NR4, O or S in which R4 is H or an optionally substituted hydrocarbon group; R5 is H, a halogen atom, C1-6 alkyl group, a C1-6 alkoxy group, a hydroxy group, a nitro group, a cyano group or an amino group wherein the C1-6 alkyl group, the C1-6 alkoxy group and the amino group may be substituted by 1 to 5 substituents, Y is C or N; ring B is an optionally substituted benzene ring; m = 1 to 4 and n = 0 to 2; L represents a leaving group such as a halogen atom, an alkylsulfonyl group, an alkylsulfonlyoxy group and arylsulfonyloxy group; or a salt thereof.
